ELIZABETH QUINN: Open Payments
NPI 1962664102 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 31 payments from 9 companies in 2025. Trend: 2023 $808 · 2024 $740 · 2025 $539
Food & beverage: $530Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $214 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
| Incyte Corporation | 3 | $72 |
| GENZYME CORPORATION | 1 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $33 |
| Amgen Inc. | 2 | $32 |
| LEO Pharma Inc. | 1 | $30 |
| UCB, Inc. | 1 | $14 |
Products named: SKYRIZI, OPZELURA, DUPIXENT, RINVOQ, COSENTYX, ILUMYA, OTEZLA, ANZUPGO.
Industry payments across WA — which companies pay providers there.
